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Introduction
We all worry. In this day and age, there are so many matters about which to worry.
However, when worrying becomes excessive or irrational or leads to unreasonable behaviors, it
would likely lead to the diagnosis of a medically recognized anxiety disorder. These disorders
can take many forms, and as with any area of mental health, their definitions and manifestations
are variable. They make up a significant component of mental health disorders worldwide and as
such, it is important to be aware of and informed about them to foster understanding and
connection with one another.
This exploration is rooted in my personal connection to anxiety disorders, as a large part
of my life and college experience has involved handling my own anxiety. The title of this paper
was inspired by a series of Bible verses that I have often read to bring some peace to my mind:
“Therefore I tell you, do not worry about your life, what you will eat; or about your body, what
you will wear. For life is more than food, and the body more than clothes. Consider the ravens:
They do not sow or reap, they have no storeroom or barn; yet God feeds them. And how much
more valuable you are than birds! Who of you by worrying can add a single hour to your life?
Since you cannot do this very little thing, why do you worry about the rest?” (Luke 12:22-26,
The Holy Bible NIV, 2011). I’d like to use this opportunity to reflect on my personal
experiences and explore the “why” and the “how” behind these feelings that I have carried for
most of my life, with the hope that it will be both personally therapeutic and impactful on others.
I have always recognized myself as an anxious person, a “Nervous Nellie,” a chronic
worrier, but only recently was I diagnosed with generalized anxiety disorder or GAD. The story
begins years and years ago, when I was a small child. One of the earliest anxious tendencies that

3
I can recall was that I often could not fall asleep if I had even the slightest need to pee. This
affected me strongly at unfamiliar locations, and I could hardly ever stay through the night at a
friend’s house. In my mind, it was the end of the world if I could not fall asleep, so I would
become panicky and upset (which only served to exacerbate my frequent trips to the bathroom).
My parents had me examined for physical health issues and the doctors told them my behavior
was caused by anxiety.
There were plenty of other instances like this in my childhood. There was a period of
time when I could not leave the house if I felt the seams of my socks pressing against my toes
inside my shoes. One day, I simply would not enter my second-grade classroom despite my
mother persistently pleading with me outside the door because I was anxious about having to
endure my stern and grumpy teacher. After an extensive argument I started running away from
my mother, down the hallway, which was very contrary to my obedient nature. As I reflect on
these experiences and more recent ones, I realize that even this obedient nature was often born
out of anxiety about getting in trouble. I was always a well-behaved student because I was too
nervous about being seen in a negative light or being punished to ever act out (and I am still like
this, for the most part).
I have also always been known as a shy, quiet girl. Growing up with a father in the Air
Force, our family moved around quite frequently, so I constantly had to make new friends and
leave old ones behind. I was not talkative or outgoing, and was never part of the “popular
crowd” in school. Making friends was not a very easy process for me. I also did not like to
interact with strangers or people that weren’t familiar to me. This was often explained by a
casual remark about my shyness, but now that I’m reflecting on this, I’m realizing that this
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shyness was probably a manifestation of the beginnings of social anxiety. I was (and still am)
nervous about judgement from both familiar and unfamiliar people.
Many of these specific childhood anxious tendencies gently faded away as I matured, but
new ones took their place as the amount of things I actually had to worry about increased. Some
of the tendencies simply resolved into new variations of the same behaviors or worries. Before
discussing more psychological and behavioral manifestations of anxiety, however, the scientist
in me would like to take a step back and delve into the brain and body to investigate the physical
basis behind these thoughts, feelings, and actions. Simply put, I’d like to explore why us anxious
people are the way we are and how our physical selves function to influence our psychological
selves.
Biological Aspects of Anxiety
A good place to start is with an exploration of the organ integral to our thoughts and
actions: the brain. Many intricate relationships between different brain components are at play
in anxiety disorders. This complicated dance is primarily carried out through interactions in the
corticolimbic system, which regulates emotions, memories, and brain regions involved in higher
cognitive processes. These interactions begin when a sensory or emotional stimulus is detected
and relayed to a structure in the brain called the thalamus. This information can then take one of
two pathways: a short, involuntary pathway that does not involve higher cognitive processes
sends information straight to the amygdala (a central component in this dance, which will be
discussed in detail shortly), while the long, voluntary pathway passes information to the
prefrontal cortex and the hippocampus before it is sent to the amygdala. There are many
reciprocal interactions between these and other areas of the brain. Information is then processed
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by the amygdala and passed on to other brain and body structures, creating physiological and
psychological responses commonly associated with anxiety or stress.
The long pathway to the amygdala is integral in anxiety disorders. Information received
by the thalamus is passed on to the prefrontal cortex, which engages in higher cognitive
processes that focus attention on the stimulus, organize memories of previous experiences, and
determine the relative significance of the stimulus under consideration. Based on this calculation,
the prefrontal cortex influences the amygdala’s “decision” on generating an anxiety response. It
can both reduce anxiety by reasoning out irrational fear, or it can increase it by causing us to
imagine scenarios that could cause anxiety (THE BRAIN FROM TOP TO BOTTOM, n.d.).
Specifically, the medial prefrontal cortex (mPFC) evaluates the threat level of the situation. The
prelimbic region of the mPFC signals to the amygdala to create a response to a threat, and the
infralimbic region signals to the amygdala to suppress a response to a threat (Calhoon & Tye,
2015). The prefrontal cortex is hypoactive in some people with anxiety disorders, and a higher
level of activation is required to control an emotional reaction in anxious people (Gauthier &
Nuss, 2015).
Connections between the dorsal anterior cingulate region of the PFC and the basolateral
amygdala (BLA) are involved in maintaining correlations between memories and the fear or
anxiety associated with them. This prevents the extinction of “fear memories,” strengthening
the association between the original anxiety-inducing situation and the anxiety itself. However,
repeated exposure to the same “threat” can reduce the signaling between these regions and the
anxiety response (Calhoon & Tye, 2015). This may be the basis of immersion therapy for the
treatment of anxiety, which will be discussed later. The prefrontal cortex is also involved in
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mediating between the anxiety or avoidance reaction and the reward reaction, in which a brain
region called the nucleus accumbens is involved (Calhoon & Tye, 2015).
The long pathway to the amygdala also involves the hippocampus, which is a key
structure for both emotional regulation and memory creation in the brain. The hippocampus can
create context for and store memories of events and therefore can increase the anxiety response
in similar events. Signaling from the amygdala to the hippocampus can strengthen such “fear
memories” (Calhoon & Tye, 2015). Additionally, signaling from the ventral hippocampus
(vHPC) to an area in the middle of the forebrain called the lateral septum (LS) can generate an
anxiety signal. This then leads to inhibition of the anterior hypothalamus, activation of a specific
region of the hypothalamus called the paraventricular nucleus, and activation of the
periaqueductal gray in the brainstem, creating an anxiety state (Calhoon & Tye, 2015).
Interestingly, the hippocampus can also be involved in negative feedback or reduction of the
anxiety response: it contains receptors for stress hormones and when these hormones bind, they
can reduce signaling to the hypothalamus and result in reduced downstream signaling (Herman
et al., 2012). The hippocampus therefore has many complex roles in the anxiety response.
A diagram containing these long pathway components is pictured below in Figure 1.
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(Leisman, 2013)

The central component in these complex circuits is the amygdala, which is responsible
for one's emotional response to a stimulus. After receiving information via one of the two
aforementioned pathways, the basolateral amygdala (BLA) activates the central amygdala (CeA).
This can then activate the hypothalamus and brainstem to create the physiological manifestations
of anxiety (Gauthier & Nuss, 2015). The BLA also activates the bed nucleus of the stria
terminalis (BNST), which further signals to other areas of the brain to increase “fear learning”
and create a fear response. The BNST is specifically involved in the freezing response during
stress. The periaqueductal gray or PAG can also be a downstream target of the amygdala, and it
is involved in this freezing behavior as well (Calhoon & Tye, 2015). The amygdala can also
signal to the ventral tegmental area in the midbrain and the locus coeruleus in the pons of the
brainstem, which may create the uneasiness felt in anxiety (Gauthier & Nuss, 2015).
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A diagram containing some of the brain regions involved in these interactions is pictured
below in Figure 2.

(Avery et al., 2015)

The physiological symptoms commonly associated with anxiety can be a result of the
activation of the sympathetic nervous system. The sympathetic nervous system is responsible for
the “fight or flight” response that is necessary in survival situations. Essentially, the
hypothalamus activates the adrenal medulla, a component of the adrenal glands (which are
located just above the kidneys), via the sympathetic ganglia (neurons in the spinal cord). This
causes them to release epinephrine, more commonly known as adrenaline. This hormone
increases heart rate, breath rate, blood pressure, and release of energy sources such as sugars and
fats into the bloodstream (Harvard Health Publishing, 2018a). If one isn’t using all of this excess
energy in an actual fight or flight response, but is instead in a non-threatening but

9
anxiety-producing situation, this can lead to physical shaking, which is a commonly experienced
symptom in anxiety.
A slower pathway termed the HPA (hypothalamic-pituitary-adrenal) axis is also receptive
of signals from the amygdala, hippocampus, and prefrontal cortex, and is heavily involved in the
neuroendocrine response in anxiety. When the amygdala is activated by the presence of a
stressor, it activates the paraventricular nucleus of the hypothalamus. This then activates the
pituitary gland, which is involved in the regulation of many hormonal glands (Watson &
Breedlove, 2018). The pituitary gland releases a hormone that travels to and activates the
adrenal cortex of the adrenal glands. These glands then release cortisol, a glucocorticoid or
stress hormone that has many physiological effects in the body (Watson & Breedlove, 2018).
Hippocampus and mPFC signaling to this axis inhibit this stress response (Smith & Vale, 2006).
A diagram tidily depicting these two pathways is pictured below in Figure 3.

(Bassi, 2017)
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The “signaling” involved in all of these intricate pathways is carried out via
communication between neurons, in which electrical and chemical signals are involved.
Essentially, neurons fire an electrical signal called an action potential when a certain membrane
potential threshold is reached in the neuron. This electrical signal causes the release of chemical
messengers into the synapse, or the space between neurons. The waves of electrical signals exist
at different frequencies, and one in particular that can be measured by an EEG, called the theta
rhythm, has been shown to play a significant role in anxiety. Theta rhythms that originate in the
hippocampus can drive and synchronize with the rhythms in the mPFC and amygdala, which has
been shown to create anxiety (Calhoon & Tye, 2015). The hippocampus is basically recognizing
and signifying a threat. Theta rhythms that originate in the PFC, however, have been shown to
create a “safety signal” and reduce anxiety when synchronized with the amygdala’s rhythms
(Calhoon & Tye, 2015).
Neurotransmitters are the chemical messengers that carry out the signaling between
neurons. They are released from one neuron (termed the pre-synaptic neuron) and bind to
receptors on another neuron (termed the post-synaptic neuron) to induce a response. The
neurotransmitter can either be excitatory, increasing the signaling potential of the post-synaptic
neuron, or inhibitory, decreasing the signaling potential of the post-synaptic neuron. An
illustration of this communication between neurons is depicted below in Figure 4.
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(NIDA, 2011)

The most common inhibitory neurotransmitter and one that is highly involved in anxiety
pathways is gamma aminobutyric acid, or GABA. It inhibits cell firing because it can be
ionotropic: essentially, the binding of GABA causes the opening of chloride channels on the
neuron. Chloride ions, which are negatively charged, then flow into the post-synaptic cell. This
hyperpolarizes the membrane potential, decreasing the neuron’s chance of firing an action
potential (Watson & Breedlove, 2018). GABA can also be metabotropic, meaning it indirectly
opens chloride channels after a sequence of other events; this causes it to induce a slow and
prolonged inhibitory response (Gauthier & Nuss, 2015).
GABA plays a major role in the regulation of the central nucleus of the amygdala, which,
as mentioned before, is a key component of anxiety pathways in the brain. Clusters of
GABAergic neurons (neurons containing GABA receptors) in the amygdala limit the activity of
the central nucleus, which when activated can induce an anxiety response after a sequence of
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downstream actions. These GABAergic neurons are activated in response to signaling from
glutamatergic neurons (neurons containing glutamate receptors) in the prefrontal cortex. If
GABA functioning is impaired, the inhibition of the amygdala is reduced and it engages in
overactive signaling (Meyer & Quenzer, 2018). This also means there is less control of the
amygdala by the prefrontal cortex. The prefrontal cortex can allow us to reason out of our fear
response, so it is essential to have properly functioning and adequate amounts of GABA to
control anxiety.
There are multitudes of pharmaceutical treatments used for anxiety disorders, and those
that act similarly to GABA are quite common. Benzodiazepines are a class of drug that bind to
some kinds of GABA receptors and increase the probability of chloride channels opening in
response to GABA, therefore making it more potent (Gauthier & Nuss, 2015). Barbiturates are
another class of drug that bind to a spot on the GABA receptor and prolong the opening of
chloride channels. They can act without GABA present, which potentially makes them more
dangerous (Meyer & Quenzer, 2018). Neuroactive steroids are another treatment option that can
act similarly to benzodiazepines and also directly activate the GABA receptor (Gauthier & Nuss,
2015). A specific drug called etifoxine can modulate neurosteroids and allosterically bind to the
GABA receptor, also reducing anxiety (Gauthier & Nuss, 2015).
Although it plays a crucial role, GABA is not the only neurotransmitter involved in
anxiety. Serotonin, a versatile neurotransmitter involved in numerous functions such as mood
regulation, also plays a part. Serotonin increases amygdala-mediated activity, and a hyperactive
amygdala can increase anxiety. It has also been shown to inhibit the periaqueductal gray,
allowing it to mediate the fight or flight response involved in anxiety (Bandelow et al., 2016). It

13
doesn’t seem to strictly increase or decrease anxiety, but rather affects it in different ways across
various areas of the brain; it seems to be more involved in balance than unidirectional change.
Drugs that mimic serotonin or cause it to accumulate can reduce anxiety, and are increasingly
being used as treatments for anxiety disorders. The most common are SSRIs, or selective
serotonin reuptake inhibitors, which prolong serotonin’s effects by allowing it to accumulate in
the synapses between pre-synaptic and post-synaptic neurons instead of immediately recycling it
back into the pre-synaptic cell (Meyer & Quenzer, 2018).
Dopamine, the “pleasure” or “motivation” neurotransmitter, also plays many roles in the
brain and in anxiety. There are many projections of neurons with dopamine receptors from the
ventral tegmental area of the brain to the mPFC and the amygdala. These are activated by
stressful stimuli and inhibit prefrontal cortex control of the amygdala, leading to a hyperactive
amygdala and increased anxiety response (Meyer & Quenzer, 2018). Increased turnover
(presence, transport, and use) of dopamine in the prefrontal cortex has also been shown to
enhance the anxiety response. Benzodiazepines, the drug previously mentioned in the discussion
about GABA, can decrease dopamine turnover (Meyer & Quenzer, 2018).
The major neurotransmitters mentioned thus far are not the only small molecules
involved in biological anxiety; numerous other hormones and neuropeptides influence the
physiological responses that we often associate with such disorders. The HPA axis, previously
mentioned as a downstream pathway of amygdala, HPC, and PFC signaling, involves many of
these hormones. When activated by the amygdala, the paraventricular nucleus of the
hypothalamus releases a hormone or neuropeptide called corticotropin-releasing factor, or CRF.
CRF is what activates the anterior pituitary gland, which releases a hormone termed
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adrenocorticotropic hormone, or ACTH (Meyer & Quenzer, 2018). ACTH travels through the
blood to activate the adrenal glands. These glands then release glucocorticoids, which have
many effects on the body (Meyer & Quenzer, 2018).
The major stress hormone or glucocorticoid in humans is cortisol. Cortisol can
participate in negative feedback by binding to the hippocampus, hypothalamus, and pituitary
gland and decreasing HPA axis signaling (Meyer & Quenzer, 2018). Glucocorticoids such as
cortisol can have other effects on the brain and body: in acute stress, they can activate
brain-derived neurotrophic factors (BDNFs), which increases neuroplasticity. However, in
chronic stress, they can have the opposite effect, suppressing BDNFs and decreasing
neuroplasticity (Bandelow et al., 2016). This means the brain cannot change and adapt as easily,
which may make people more prone to repeating their same anxious behaviors. Levels of
cortisol vary widely among people with various anxiety disorders, so it is not the sole
determining factor of anxiety (Bandelow et al., 2016).
CRF, also called corticotropin releasing hormone (CRH), has additional effects in the
brain. Sensitivity to lower levels of CRF can increase the release of norepinephrine or NE, a
neurotransmitter involved in the physiological responses associated with anxiety (Meyer &
Quenzer, 2018). Anxious people can develop this sensitivity because their bodies are exposed to
CRF frequently, so it engages in a sort of positive feedback. The turnover of NE is then
increased in the amygdala, hippocampus, hypothalamus, and prefrontal cortex (Meyer &
Quenzer, 2018). A region in the brainstem called the dorsal pons contains a collection of
noradrenergic cells (cells that respond to NE) called the locus coeruleus, or LC. This area,
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involved in arousal and sensory processing, is activated by CRF and inhibited by GABA and
serotonin (Meyer & Quenzer, 2018).
Norepinephrine is a neurotransmitter and hormone that is primarily involved in the
activation of the sympathetic nervous system. It is released at sympathetic nervous system organ
sites and causes increased heart rate, pupil dilation, and other physiological responses that
commonly occur in anxiety. It is also involved in the formation of emotional memories,
associating certain events with feelings of anxiety and therefore increasing the anxiety response
when a similar event occurs (Meyer & Quenzer, 2018). Hyperfunction of NE and the
stimulation of the locus coeruleus in the brain are often associated with anxiety (Bandelow et al.,
2016).
Interestingly, numerous drugs used in the treatment of anxiety disorders act on both
serotonin and norepinephrine. Certain drugs called SNRIs (serotonin and norepinephrine
reuptake inhibitors) act similarly to SSRIs and prevent the reuptake of both serotonin and
norepinephrine, which can have anxiolytic effects (Farach et al., 2012). A class of drugs called
tricyclic antidepressants (TCAs) act similarly, increasing the levels of both of these
neurotransmitters (Roy-Byrne, MD, 2019). Monoamine oxidase inhibitors, or MAOIs, inhibit
the activity of the enzyme monoamine oxidase, which is involved in the breakdown of serotonin
and norepinephrine. This means it also increases the levels of these neurotransmitters in the
brain (Anxiety Disorders Association of America, 2009). It seems odd that increasing levels of
norepinephrine can have anxiolytic effects, since norepinephrine generally acts to increase
anxiety-related physiological responses. This “noradrenergic paradox” has been investigated,
and a possible explanation is that norepinephrine can activate “autoreceptors” on the neurons
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from which it was released, which in turn inhibits those neurons from releasing more
norepinephrine. As such, it participates in a sort of negative feedback (Blier & Briley, 2011).
There are other neuropeptides involved in anxiety that are not as well-known but are
worth discussing. For example, cholecystokinin (CCK) is a neuropeptide found in
anxiety-related areas of the brain such as the basolateral amygdala, hypothalamus,
periaqueductal gray, and anterior cingulate cortex or ACC (Bandelow et al., 2016). CCK
activates neurons in the amygdala, interacts with neurotransmitters such as serotonin and GABA,
and increases production of glutamate (an excitatory neurotransmitter) in the ACC (Bandelow et
al., 2016). The ACC is involved in processing negative emotions and anticipating unpleasant
stimuli, so overactivity could be a biological explanation for the unnecessary apprehension felt in
anxiety (Martin et al., 2009). An interesting side note is that CCK is also involved in digestion,
as it stimulates the release of digestive enzymes from the pancreas and bile from the gallbladder
to aid in digestion (Cholecystokinin, 2020). This may explain why people experience a “nervous
stomach” during periods of anxiety; their digestion may be accelerated by CCK.
Atrial natriuretic peptide (ANP) is also involved in the modulation of anxiety. ANP
specifically inhibits the release of ACTH and cortisol, acting as an anxiolytic hormone and
decreasing HPA axis activation. Physical activity can actually increase ANP levels, which may
be part of the reason why exercise is beneficial for anxiety reduction (Bandelow et al., 2016).
Finally, oxytocin (the “love hormone”) decreases activation of the amygdala and brainstem in
response to stress (Martin et al., 2009). It has specifically been shown to ease social anxiety by
activating GABAergic neurons in the amygdala and increasing the likelihood of pleasant social

17
interactions (Labuschagne et al., 2010). Perhaps this is why we feel so comforted around our
loved ones; oxytocin is creating that feeling of safety.
It is apparent that there are multitudes of factors that contribute to the mental state known
as anxiety, and it is interesting to consider how all of this can affect one’s overall health. To
begin, a consistently activated sympathetic nervous system has detrimental effects on
cardiovascular health. For example, frequent release of adrenaline increases the risk of heart
attacks and strokes by damaging blood vessels and increasing blood pressure (Harvard Health
Publishing, 2018a). In addition, increased levels of HPA activity and release of cortisol can
cause fat buildup and weight gain, which can have further negative effects on the body (Harvard
Health Publishing, 2018a). It doesn’t appear that there are many other well-studied direct
causations between anxiety and other aspects of physical health, but various studies have been
conducted to investigate the correlations between anxiety disorders and conditions such as
gastrointestinal disorders, chronic respiratory disorders, and heart disease. Correlations between
respiratory disorders such as chronic obstructive pulmonary disease (COPD) and anxiety
disorders in individuals are high. In addition, the likelihood of a heart attack in individuals with
heart diseases is higher for those with anxiety disorders (Harvard Health Publishing, 2018b). A
specific study looking at an elderly population reported an association between gastrointestinal
disorders, such as irritable bowel syndrome and Crohn’s disease, and anxiety and depression
(Kang et al., 2017). Although exact mechanisms are not well understood, it is apparent that
anxiety is not beneficial to overall physical health.
There are numerous biological factors involved in anxiety. But this begs the question of
why some people’s brains repeatedly trace the stress circuit, or have less potent responses to
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inhibitory neurotransmitters, or possess any of these other traits that cause anxiety. Is it
preordained, in our genetics, or does it all depend on the environment in which we were raised?
Both can come into play. Anxiety is such a complex phenomenon; numerous genes are involved
and therefore a direct causal relationship between genetics and anxiety is difficult to pin down.
However, various genes that affect factors such as serotonin transport and necessary proteins
such as BDNF (which is important in the growth and development of neurons) can play roles in
anxiety (Sharma et al., 2016). Studies have been conducted in animals that show that
epigenetics, which is the control of gene expression via methods such as DNA methylation, can
alter the expression of genes such as these that contribute to the “stress circuits” in the brain and
body (Meyer & Quenzer, 2018). There is evidence that experiencing stress and trauma early on
in life can affect genetic expression and brain development and increase the likelihood of anxiety
later on, so genetics and environment are undoubtedly linked (Meyer & Quenzer, 2018).
I have often wondered how genetics and environment have affected my anxious
tendencies. As was mentioned earlier, I’ve had these tendencies since I was a young child, but to
my knowledge I didn’t experience intense amounts of stress or any trauma. I had a very safe and
sheltered childhood. But perhaps this safe and sheltered childhood contributed just the same. I
was constantly warned about the dangers in the world and heavily protected from them by my
parents, which likely influenced the amount of fear I carried with me in many situations.
Perhaps some of my anxious tendencies are attempts to harness control over my life, given that
there are so many things I was taught I do not have control over. My mother also has anxious
tendencies, and only now that I’m older do I realize that perhaps I subconsciously adopted
similar ones when I was younger. It also supports the idea of a genetic component; if anxiety
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runs in my family, perhaps I was genetically predisposed. It’s all very interesting to speculate
on, and although there is no clear-cut way to explain the cause, it’s likely that many factors have
come into play in my personal experiences.
It is clear that anxiety has its roots in the physical body. Much of what we think and feel
can be attributed to chemical and electrical messages traveling around the brain and body. But
the stimuli that can trigger these messages, and their manifestations, make up another side of
anxiety that has its own form of complexity. The psychological and behavioral aspects of
anxiety disorders are equally if not more important in studying this multifaceted phenomenon.
To explore this side of anxiety disorders, it’s important to distinguish the fact that anxiety
disorders are often categorized based on what sets off the anxiety response and how the
individual reacts. For this exploration, I’d like to focus on three forms: generalized anxiety
disorder (GAD), social anxiety disorder (SAD), and obsessive-compulsive disorder (OCD). I
have had personal experiences with GAD and SAD, and have not been diagnosed with OCD, but
I take an interest in it given some of the forms in which my personal anxiety manifests.
Psychological and Behavioral Aspects of Anxiety
A good starting point for the discussion on this side of anxiety disorders is generalized
anxiety disorder, or GAD. The most recent Diagnostic and Statistical Manual of Mental
Disorders, the DSM-V, gives criteria for diagnosing GAD. These include “the presence of
excessive anxiety and worry about a variety of topics, events, or activities” that is experienced
for at least six months and is “very challenging to control” (Glasofer, PhD, 2020; American
Psychiatric Association, 2013). Essentially, it seems that the anxiety response isn’t necessarily
triggered by a specific situation, but is rather a frequent underlying mindset. GAD is diagnosed
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when an individual has uncontrolled worry in addition to at least three other symptoms, which
include things such as sleep trouble, muscle tension, and restlessness (Glasofer, PhD, 2020;
American Psychiatric Association, 2013). Many of these physiological symptoms are logical
results of the previously discussed stress response in the body.
I was recently diagnosed with GAD by my primary care doctor. Interestingly enough,
she didn’t ask me any specifics about how long my worry had been going on or if I experienced
any characteristic symptoms. She just noticed that I pick at my skin and asked if I was stressed,
and when I said yes, it became “official.” I do agree that I often worry about many things.
When I have to enter an unfamiliar situation or undergo something that has caused me stress
before, I get extremely worried beforehand and exhibit lots of the symptoms commonly
associated with anxiety - shaky hands, nervous stomach, racing heart. These symptoms often
persist for some of the actual event, but are usually worse prior to it. Even when no dire
consequences are likely, my nerves like to take over; it’s almost habitual at this point. Now I
know that this is likely due to the links between my amygdala, prefrontal cortex, and
hippocampus, strengthening the association between bad memories and the anxiety response.
An example of this would be my experiences in science labs as an undergraduate. I took
Honors Chemistry my freshman year at WWU, and I found the labs to be very stressful due to
their level of difficulty and my inexperience. I tend to put a lot of pressure on myself in my
academics, so I wanted to get good grades, and these grades depended on how well experiments
turned out in the lab. But science experiments aren’t as easy to control as other types of
assignments, and the restrictions on resources and time limits did not help (I do not do well under
time pressure). I think part of my anxiety surrounding these labs was due to my lack of control -
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I couldn’t make t he science “go right” all of the time. My nerves also caused my hands to shake,
which made handling the equipment and doing just about everything that required dexterity very
difficult. This would exacerbate my anxiety, and thus began a perpetual unpleasant cycle. From
there on out, I would get very nervous before every chemistry lab I had to take, and even some
biology labs. As a cell and molecular biology major, I’ve had to take many labs, so this anxious
state was quite frequent.
It’s interesting that I was diagnosed with GAD, because as is apparent in the example
above, it seems as if my anxiety is almost always triggered by a specific situation - it’s just that
there are many situations that can trigger it. Aside from chemistry labs, I get nervous about
driving unfamiliar routes, driving other people around, talking on the phone, interpersonal
conflicts and having to resolve them, speaking up, and making decisions, to name a few. But it
seems to me that GAD often puts one into a state of anxiety where one can’t even distinguish a
cause. Perhaps I am often spun up into an anxious state without a real cause, but my rational
mind won’t accept this, and thus pins it on something concrete so my mind can explain itself to
me.
I’d next like to discuss a specific form of anxiety that I feel I’ve had experiences with my
whole life: social anxiety. The DSM-V gives diagnostic criteria for SAD that include “marked
fear or anxiety about one or more social situations in which (one) might be scrutinized by others”
and “fear that (one) will humiliate or embarrass (one)self and be rejected by others.” The
anxiety is often “out of proportion to the actual threat of the situation” and “interferes with many
areas of life” ( Cuncic, 2019; American Psychiatric Association, 2013).  SAD is a relatively
common anxiety disorder that often starts in early childhood and can be contributed to by both
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environmental and genetic factors (NIMH » Social Anxiety Disorder: More Than Just Shyness,
2018). People with social anxiety often experience typical anxiety symptoms such as trembling
and nausea when in many social situations, and can be very self-conscious in or avoidant of such
situations (Cuncic, 2019). This obviously has detrimental effects on day-to-day life.
I mentioned before that I was extremely shy at a young age. As a child, I was always
very nervous about meeting new people, and sometimes had trouble making friends or feeling
fully included and accepted. This has improved since I’ve gotten older, but I am still not one for
“putting myself out there.” Most people would describe me as very quiet and introverted, which
are not bad things in and of themselves, but some of the reasons behind why I am those things
isn’t great for my mental health. I am often afraid to speak up because I am afraid of what
people will think of me. Unfamiliar or potentially uncomfortable social situations make me very
nervous, and I tend to avoid them unless I am with people around whom I feel comfortable.
Even simple phone calls give me adrenaline rushes.
I have also struggled with having the confidence to speak out in academic settings, and
rarely am able to make voluntary verbal contributions in class, even if I think I know the answer
or have an interesting thought. It’s like my brain physically blocks my hand from going up or
my mouth from forming words, and I feel that I cannot speak. When I do have to speak out in
front of people, my sympathetic nervous system decides to throw a party and my heart races, my
stomach churns, and my hands tremble. Interestingly enough, this has gotten worse as I’ve gone
through college. I think it’s partially because I’m surrounded by incredibly intelligent peers, and
I am (irrationally) terrified of their judgement. However encouraging people are to me about
sharing my thoughts, my brain convinces me that I will get something wrong and then, due to my
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brain’s tendency to perpetually replay my mistakes, I will never forget it. This also makes me
enthusiastically uninterested in public speaking. I think making myself do these things will help
- I just have to overcome the mental barriers, which is not easy.
A final anxiety-related disorder that I haven’t been diagnosed with but I feel a connection
to is obsessive-compulsive disorder, or OCD. Interestingly, OCD was previously included under
the umbrella of anxiety disorders in the Diagnostic and Statistical Manual of Mental Disorders,
but in the most recent DSM-V, OCD is under its own category of “Obsessive-Compulsive and
Related Disorders.” Anxiety still does play a role. The DSM-V provides criteria for diagnosis of
OCD, which is defined as the “presence of obsessions, compulsions, or both.” Obsessions are
described as “Recurrent and persistent thoughts, urges, or images that are experienced...as
intrusive and unwanted, and that...cause marked anxiety or distress” that the person “attempts to
ignore or suppress… or to neutralize… with some other thought or action” (Fenske, MD &
Petersen, MD, 2015; American Psychiatric Association, 2013). Compulsions are described as
“repetitive behaviors… or mental acts...that the individual feels driven to perform in response to
an obsession or according to rules that must be applied rigidly” that are “aimed at preventing or
reducing anxiety or distress, or preventing some dreaded event or situation.” The compulsions
may be directly connected to the obsessions (such as hand washing in response to obsessive
thoughts about contamination) but may not have a logical connection to the obsessive thoughts
(Fenske, MD & Petersen, MD, 2015; American Psychiatric Association, 2013). The thoughts
and behaviors are generally quite difficult to control, and compulsions typically tend to take up a
significant amount of time in day-to-day life (Obsessive-Compulsive Disorder (OCD) | ADAA,
2019).
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I don’t want to self-diagnose, or undermine the severity of this actual disorder with my
potentially less potent experiences. I just think it’s interesting to examine some of my anxious
tendencies through this lens. I’ve already mentioned that I consider myself a chronic worrier,
but I don’t know how obtrusive I should consider my thoughts to be, because I sometimes feel
that there is a logical reason for my worries. I wash my hands more often than the average
person and if I touch someone else’s hands or something my brain considers “contaminated,” I
have the thought of that contamination in the back of my mind until I wash my hands. I’ve also
always been a person of routine, but sometimes, it does seem to get out of hand. For example,
even if I know that I checked to make sure the back door was locked, my brain will tell me to
check it again, because what if it was actually unlocked and someone broke in? These types of
thoughts aren’t omnipresent, but do play a large part in my life.
Something that I do repetitively, uncontrollably, and irrationally is ruminate on past
mistakes. When I make a mistake that my brain decides to fixate on, whether it actually has an
impact on my life or (more often) does not, it becomes like an itch in my brain that I can’t
scratch unless the issue is resolved. The issue often cannot be resolved because it happened in
the past, so it is very difficult for my brain to ignore it. The mistake starts playing in a repeating
loop in my head, and sometimes the track wears out quickly, but other times it sticks around for
an absurd amount of time; sometimes it’ll even fade away but then come back much later on and
start replaying again. This frustrating unpleasantness exacerbates my fear of making mistakes
and therefore my overall anxiety in many situations. I also have a tendency to pick at my skin,
especially when I’m in a stressful situation or stuck in a bout of rumination. There is a disorder
that is categorized under the same heading as OCD in the DSM-V that involves compulsive
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skin-picking (Diagnostic and Statistical Manual of Mental Disorders and OCD | OCD-UK,
2013). I often have trouble controlling this behavior, however unwanted it is. It is interesting to
examine how the symptoms I personally experience can overlap and connect with symptoms
experienced in other mental health disorders, as this sort of connection can increase the empathy
we feel for each other.
Having anxiety-related disorders can obviously be detrimental to physical and mental
health and can make everyday life difficult. However, there are numerous treatments available,
ranging from medications that directly target the neurochemical aspects to behavioral therapies
that target the psychological side. Anxiety disorders are so complex, it is logical that treatments
work differently for different people, and it is not able to be entirely streamlined. There are,
however, common therapies that work well for large groups of people. I’d like to discuss these
in a little more depth.
Treatment
To start, we can touch back on the pharmacological side of anxiety treatment. There are
many medications currently on the market for anxiety disorders, and they use varying
mechanisms to alleviate symptoms in the brain. One of the most well-known classifications of
drugs is the central nervous system (CNS) depressants, which include the aforementioned
benzodiazepines and barbiturates. These drugs enhance the effects of the inhibitory
neurotransmitter GABA, reducing feelings of stress (Meyer & Quenzer, 2018). This is
especially significant because research has shown that lower numbers of GABA receptors and
abnormalities in the regulation of GABAergic neuron signaling have been observed in people
with anxiety disorders (Martin et al., 2009). Benzodiazepines in particular have been commonly
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prescribed for GAD, SAD, and OCD, and can be used regularly or in cases of situational anxiety
(Meyer & Quenzer, 2018). However, current research is suggesting that they are not the best
option for primary treatment, as they may cause dependence when taken over extended periods
of time and withdrawal symptoms when attempting to stop taking them (Bandelow et al., 2017).
They may also have serious side effects involving depression of the CNS, manifesting in
symptoms such as slower reaction time and dizziness, and may have detrimental cognitive
effects (Bandelow et al., 2017).
Drugs commonly classified as antidepressants are also useful in the treatment of anxiety
disorders (Anxiety Disorders Association of America, 2009). Selective serotonin reuptake
inhibitors (SSRIs) and serotonin-norepinephrine reuptake inhibitors (SNRIs) are commonly
prescribed for pharmacological treatment of anxiety disorders. They sometimes take a few
weeks to have any beneficial effects, and can initially make anxiety symptoms worse (Bandelow
et al., 2017). However, after this initial time, these drugs are often effective. For example, in a
meta-analysis study, Jakubovski et al (2019) found that both SSRIs and SNRIs have significantly
beneficial effects on anxiety symptoms compared to placebo treatments, specifically in SAD.
SSRIs in particular have better efficacy with increased dosage, but this also increases unpleasant
side effects, so a balance must be attained (Jakubovski et al., 2019). Other antidepressants, such
as tricyclic antidepressants (TCAs) and monoamine oxidase inhibitors (MAOIs), are also
occasionally prescribed to treat anxiety disorders. However, TCAs have more detrimental side
effects and overdoses are lethal, so they are more risky (Farach et al., 2012). MAOIs can have
disastrous interactions with other medications and dietary tyramine, so they are not often used
(Bleakley & Davies, 2014).
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Other medications on the market for treatment of anxiety disorders include
anticonvulsants, such as pregabalin, which blocks voltage-gated calcium channels involved in
neurotransmitter release and has similar inhibitory effects as benzodiazepines with less adverse
side effects (Farach et al., 2012). A noteworthy drug called buspirone, which has been effective
in treating GAD, acts similarly to SSRIs and also has similar anxiolytic effects to
benzodiazepines, with less adverse side effects on the CNS and less risk of dependence (Meyer
& Quenzer, 2018). There are many others, and this is an ever-expanding field in which much
research is being conducted. As more is discovered about the neurochemistry behind anxiety,
more pharmacological solutions will likely take form.
Medication is a very valid treatment option for many people with anxiety disorders. As
with any sort of medical treatment, different medicines work in varying capacities for different
individuals - there is no “one size fits all” mentality when it comes to pharmacology and anxiety.
Personally, I have always been skeptical of anti-anxiety drugs for treatment of my anxiety. The
first thing my primary care doctor suggested when she diagnosed me with GAD was for me to
start medication, which is interesting to me, because there are lots of other options out there. I
guess it feels almost like a personal defeat if I can’t control my anxiety with my own willpower
and strength of mind. I also don’t want to become dependent on a substance or have things
“messing with my mind;” again, this is mostly a personal-strength dilemma, but there is the
possibility of physiological dependence with some of these medications. I’m sure there are
many opinions on whether or not anti-anxiety medication is over-prescribed, and I don’t want to
make a judgement. Nevertheless, although medication works for lots of people, it is not the only
treatment for anxiety.
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A fairly well-known and very common method of treatment for anxiety disorders and
many other mental health disorders is cognitive behavioral therapy, or CBT. CBT is defined as
“psychotherapy aimed at correcting negative thinking and consciously changing behaviors as a
way of changing feelings” (Watson & Breedlove, 2018). One of the major forms of CBT is
exposure therapy, in which the person is repeatedly exposed to the anxiety-inducing stimulus in a
controlled setting (like a therapy session) to gradually reduce the fear associated with it. This
works by essentially re-wiring the “associative networks” or “cognitive fear structures” in the
brain (Kaczkurkin & Foa, 2015). These are likely made via connections between the amygdala,
prefrontal cortex, and hippocampus when establishing irrational “fear memories” in response to
non-harmful stimuli, as mentioned earlier (Calhoon & Tye, 2015). The controlled repeated
exposure to the anxiety-inducing stimulus and formation of new memories feeds “corrective
information” into this fear circuit, allowing one to “relearn” the situation, replace the fear
memories with pleasant ones, and experience reduced anxiety when the stimulus is encountered
in a real-life situation. This exposure could be in the person’s imagination or in real life
(Kaczkurkin & Foa, 2015). For GAD and SAD, this could take the form of imagining and
talking through worry-inducing situations, or putting oneself in feared social situations. For
OCD, this could take the form of exposing oneself to an inducer of obsessive thoughts (such as
contamination) and not p erforming the compulsive ritual afterward (such as not washing the
hands x amount of times). Many studies have been conducted that show that this method of
therapy is effective (Kaczkurkin & Foa, 2015).
Another form of CBT is simply called cognitive therapy. This method essentially targets
negative thoughts with the hopes of then changing negative feelings and behaviors (Kaczkurkin
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& Foa, 2015). It seems that the general idea behind this method is for a professional, such as a
therapist, and an anxious patient to have discussions about the patient’s negative thoughts. The
professional talks with the patient about the reasoning behind irrational thoughts and encourages
the patient to analyze those thoughts, recognize faults in said thoughts, and gradually become
able to convince themselves to lend less weight to them. For example, in GAD, a patient could
be encouraged to identify thoughts that “overestimate risk” in certain situations. In SAD, a
patient could be taught that the reason certain social situations are anxiety-inducing is because
they tend to have a weak self-image and overestimate the harm a mistake could cause, and the
patient would hopefully be able to implicate better patterns of thought to address this and reduce
their fear (Kaczkurkin & Foa, 2015). In OCD, a patient may be encouraged to identify
connections between triggers, obsessive thoughts, and the importance they place on these
thoughts that leads to compulsive behaviors, and then begin to work through these connections.
Cognitive therapy alone has not been shown to be significantly effective in GAD and OCD
treatment, but it has proven effective in SAD compared to controls (Kaczkurkin & Foa, 2015).
More study is needed on this type of therapy.
I personally like the idea of cognitive-behavioral methods of treatment for anxiety more
than medication, possibly because they give one more control over the situation and allow one to
make noticeable, active steps towards wellness. Another medical professional whom I’ve talked
to about anxiety recommended that I start seeing a counselor or therapist, and although I haven’t
yet, I know plenty of friends who do and they say it makes a large difference on their mental
health. No doubt exposing oneself to anxiety-inducing situations, talking about one’s deepest
fears, and convincing oneself to engage in different patterns of thought is a very difficult
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journey, but it has beneficial outcomes in the long run. I sometimes try these methods on my
own, especially engaging in different thought patterns, and it is definitely difficult to maintain;
the “anxious portion” of my brain often wins out. But with willpower and practice, perhaps it
will improve.
Medication and cognitive behavioral therapy are not mutually exclusive; in fact, some
people engage in both methods of treatment. However, in studies conducted to determine the
effectiveness of a combination of the two types compared to each individually, the results vary.
For example, Crits-Christoph et al. conducted a study comparing the effectiveness of venlafaxine
(an SNRI) and CBT alone and a combination of the two, and did not find any significant benefit
of the combination treatment (2011). Other studies have found that a combination of
benzodiazepines and CBT can be worse than one form individually (Singewald et al., 2015).
However, one meta-analysis study that compared many of these studies did find that a
combination could be effective (Bandelow et al., 2017). In addition, certain drugs (such as
SSRIs and noradrenergic agonists) that act on biological components involved in anxiety can act
as “cognitive enhancers” and improve the effectiveness of CBT by decreasing the potency of fear
memories (Singewald et al., 2015). Considering the fact that anxiety is both biological and
psychological, it makes sense that a more holistic treatment approach could be beneficial. More
studies are needed to determine a consistent trend.
One rather unorthodox method of treatment I came across while researching is neural
circuit reprogramming. This plays off of the idea of rewiring the associative or cognitive fear
networks in the brain, as mentioned for CBT. In CBT, this is accomplished through thought
patterns and behaviors. By contrast, in neural circuit reprogramming, the idea is to physically
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manipulate these circuits in the brain via methods such as transcranial magnetic stimulation
(TMS) or focal ultrasound targeting certain positions in these fear memory circuits (Calhoon &
Tye, 2015). By up-regulating or down-regulating activity in certain circuits of the brain,
beneficial downstream effects such as reduced fear memories could occur (Calhoon & Tye,
2015). There are many considerations to take into account with this sort of study, such as other
effects on the brain, safety, invasiveness, and ethical concerns (Tye, 2014). Although this is an
interesting idea, it seems to me as if it crosses personal boundaries and it’s not something I
would ever want to undergo.
A holistic therapeutic method for anxiety treatment is exercise. Numerous studies have
shown the benefits of exercise on both the body and the brain, and it is encouraged as a
therapeutic strategy for countless diseases and disorders. Physically, exercise activates the
sympathetic nervous system and the HPA axis, increasing the production of glucocorticoids such
as cortisol (Stranahan et al., 2008). This activation induces physical symptoms such as fast heart
rate, which is crucial in exercise and occurs unnecessarily in anxiety. The exact mechanism of
how this reduces overall anxiety isn’t clear, but perhaps it has something to do with the
autoreceptors and negative feedback idea mentioned earlier in the discussion about the
noradrenergic paradox. Purposeful, healthy stimulation of the sympathetic nervous system may
reduce the likelihood of activation in non-threatening but anxiety-inducing situations.
Additionally, as mentioned previously, glucocorticoids can activate brain-derived neurotrophic
factors (BDNFs), increasing neuroplasticity (Bandelow et al., 2016) and providing more
opportunities for re-wiring of fear circuits. BDNFs can also have anxiolytic effects (Anderson &
Shivakumar, 2013). Exercise can also increase blood flow to the brain and levels of beneficial
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neurotransmitters such as serotonin, norepinephrine, and the endogenous opioids known as
endorphins, which can have beneficial effects on mood (Anderson & Shivakumar, 2013). Also,
muscle tension can be reduced in physical activity, further contributing to feelings of relaxation
(Ratey, 2019).
Exercise has lots of physical benefits, as is apparent, but it can have psychological
benefits as well. Exercise can increase self-efficacy, or the idea that one is competent and able to
manage potential threats (Anderson & Shivakumar, 2013). It can also serve as a distraction from
worries, or a healthy escape from the anxiety of everyday life. Interestingly, it can also work as
a form of exposure therapy: if the person is worried about physical symptoms of anxiety such as
fast heart rate and this is attained safely in aerobic exercise, the associated fear could decrease
(Anderson & Shivakumar, 2013). It is clear that exercise has many beneficial effects on physical
and mental health, and can serve as a very helpful and low-risk therapeutic strategy. I am trying
to implicate exercise regularly into my life, and it does sometimes make me feel more relaxed.
It’s a good disperser of “anxious energy” for me.
The form of exercise that I am most inclined to participate in is dance. I started dancing
when I was four years old, and I took classes all the way up through sophomore year of high
school. I then continued dancing in musical theater throughout high school. I have also been
participating in WWU Glee Club throughout my entire college experience and was the dance
coordinator for the past three years. I consider dance a therapeutic activity. It takes my mind off
of worries and instead focuses my thoughts on my movements and how my body feels as I push
through those movements. I truly feel at home and confident when I dance, and it’s one of the
only things that I hardly ever get anxious about doing in front of people; in fact, I love
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performing dance routines. The therapeutic aspect of it likely comes in part from the beneficial
physiological effects of exercise mentioned above. I think a large part of it is the confidence it
instills in me; lack of self-confidence is a weakness I possess that contributes to my anxiety, but
when I’m dancing, I’m secure in who I am and sure of myself.
Another one of my favorite personal therapeutic activities (and one that I know I share
with lots of people) is listening to music. Music is incredibly powerful; it can evoke poignant
memories and emotional responses. There is biological evidence that listening to music can
reduce stress by activating numerous portions of the brain, increasing dopamine release and
decreasing cortisol levels in the blood (Suttie, 2015). Music has been an omnipresent entity in
my life; it’s played a large role in my dance and musical theater experience, and often
accompanies me in my day-to-day activities. It is definitely therapeutic for me: it’s amazing
that some songs have the power to mentally transport me away from my present anxious
thoughts and immerse my mind in the experience and emotions that the music is creating. It
feels like the act of processing the music and the emotions it evokes can overpower the anxiety
circuitry firing away rapidly in my brain. This love of music is a shared quality worldwide,
which goes to show how incredible of a phenomenon it is.
Something that I love to do in an almost therapeutic way is read books. I’ve been an avid
reader since I was very young, often choosing to step into a fantastical story with imaginary
characters over actively engaging with real people. I’ve started to wonder why I love it so much,
and I think it has to do with the fact that when I read a book, it allows me to momentarily escape
my own life and problems and enter someone else’s story. It can give me temporary relief from
anxious thoughts. It can also open up my mind to different perspectives, which helps me put my
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own life into perspective and appreciate all of the things I should be grateful for instead of
worrying about relatively miniscule personal issues. Books are monumentally impactful.
A final aspect of my life that helps with my anxiety is my spirituality. I was raised a
Christian and grew up attending church semi-regularly, and I still make a habit of doing so.
However, the organized portion of my religious life is not necessarily the most impactful part. It
is comforting to be able to trust in a higher presence, because so many things are outside of our
control and unknowable to us, and I think this is why so many people choose to be religious. I
personally believe that life has a deeper and higher meaning to it than what can be explained by
humans, and this is what spirituality means to me. It is difficult, but I use my spirituality to work
on trusting the idea that everything happens exactly as it should, which can greatly decrease my
anxiety.
It is clear that anxiety is a multifaceted entity, encompassing biological and behavioral
components that intricately integrate to create experiences. The experiences involved aren’t
necessarily pleasant, but being informed about how and why they occur both satiates my
academic curiosity and helps attenuate some of the negativity surrounding my thoughts and
experiences. It is also evident that although anxious tendencies can seem unbeatable at times,
there are many ways to go about alleviating them. Anxiety disorders are prevalent in society,
and understanding their mechanisms can increase acceptance of and compassion towards
ourselves and others. This exploration has been personally therapeutic and will hopefully foster
awareness and understanding, allowing us to “consider the ravens” and achieve peace both
within ourselves and with each other.
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